Articles published by Amneal Pharmaceuticals, Inc.
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Amneal Adds Two Denosumab Biosimilars to U.S. Pipeline, Expanding Oncology Portfolio
October 12, 2023
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20231005750308/en/1903088/22/AMRX_Logo.jpg)
Amneal to Report Third Quarter 2023 Results on November 7, 2023
October 05, 2023
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20230906918972/en/803761/5/amneallogo.jpg)
Amneal Receives U.S. FDA Approval for Calcium Gluconate Injection
September 06, 2023
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20230906340098/en/803761/5/amneallogo.jpg)
![](https://mms.businesswire.com/media/20230906953583/en/803761/5/amneallogo.jpg)
Amneal Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate
September 06, 2023
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20230829114108/en/1877463/22/Picture2.jpg)
![](https://mms.businesswire.com/media/20230825020989/en/803761/5/amneallogo.jpg)
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20230824209527/en/803761/5/amneallogo.jpg)
![](https://mms.businesswire.com/media/20230804762364/en/803761/5/amneallogo.jpg)
![](https://mms.businesswire.com/media/20230726946342/en/803761/5/amneallogo.jpg)
Amneal Submits Abbreviated New Drug Applications to U.S. FDA for Three Key Complex Generics
July 26, 2023
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20230706518829/en/803761/5/amneallogo.jpg)
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20230703416732/en/803761/5/amneallogo.jpg)
![](https://mms.businesswire.com/media/20230703031013/en/803761/5/amneallogo.jpg)
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20230615797558/en/803761/5/amneallogo.jpg)
![](https://mms.businesswire.com/media/20230614992379/en/803761/5/amneallogo.jpg)
![](https://mms.businesswire.com/media/20230524005198/en/803761/5/amneallogo.jpg)
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20230516005033/en/803761/5/amneallogo.jpg)
![](https://mms.businesswire.com/media/20230505005073/en/803761/5/amneallogo.jpg)
![](https://mms.businesswire.com/media/20230417005023/en/803761/5/amneallogo.jpg)
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20230417005349/en/803761/5/amneallogo.jpg)
![](https://mms.businesswire.com/media/20230412005047/en/803761/5/amneallogo.jpg)
Amneal to Report First Quarter 2023 Results on May 5, 2023
April 12, 2023
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20230302005110/en/803761/5/amneallogo.jpg)
![](https://mms.businesswire.com/media/20230302005108/en/803761/5/amneallogo.jpg)
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20230131005199/en/803761/5/amneallogo.jpg)
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20230104005120/en/803761/5/amneallogo.jpg)
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20221220005028/en/803761/5/amneallogo.jpg)
Amneal Announces 26 Generic New Product Launches in 2022 and First Injection Large Volume Bag Approval
December 20, 2022
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20221123005119/en/803761/5/amneallogo.jpg)
Amneal to Participate at Upcoming Investor Conferences
November 23, 2022
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20221122005327/en/803761/5/amneallogo.jpg)
Amneal Launches Second Biosimilar with RELEUKO® (filgrastim-ayow) in the United States
November 22, 2022
Via Business Wire
Tickers
AMRX
![](https://mms.businesswire.com/media/20221109005842/en/803761/5/amneallogo.jpg)
![](https://mms.businesswire.com/media/20221104005076/en/803761/5/amneallogo.jpg)
Amneal Reports Third Quarter 2022 Financial Results
November 04, 2022
Via Business Wire
Tickers
AMRX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.